Lim SH, An M, Lee H, et al. Determinants of Response to Sequential Pembrolizumab with Trastuzumab plus Platinum/5-FU in HER2-Positive Gastric Cancer: A Phase II Chemoimmunotherapy Trial. Clinical cancer research : an official journal of the American Association for Cancer Research. 2025:OF1-OF15. doi:10.1158/1078-0432.CCR-24-3528
Publications
Lam KP, Harris C, Taylor ML, et al. Sex Differences in B Cells from the Joints of Children with Oligoarticular Juvenile Idiopathic Arthritis. Arthritis & rheumatology (Hoboken, N.J.). 2025. doi:10.1002/art.43157
Proctor EJ, Frost HR, Mantri B, et al. Fibrinogen-binding M-related proteins facilitate the recruitment of plasminogen by Streptococcus pyogenes. Protein science : a publication of the Protein Society. 2025;34(4):e70078. doi:10.1002/pro.70078
Lee R, Ong J, Waisberg E, et al. Potential Risks of Ocular Molecular and Cellular Changes in Spaceflight. Seminars in ophthalmology. 2025:1-11. doi:10.1080/08820538.2025.2471443
Blumstein M, Webster S, Hopkins R, Basler D, Yun J, Marais DLD. Genomics highlight an underestimation of phenology sensitivity to the urban heat island effect. Proceedings of the National Academy of Sciences of the United States of America. 2025;122(12):e2408564122. doi:10.1073/pnas.2408564122
Rehm HL. Building Biobanks to Drive Biomedical Research and Genomically Informed Care. JAMA network open. 2025;8(3):e250925. doi:10.1001/jamanetworkopen.2025.0925
Ngo JM, Williams JK, Zhang C, et al. Extracellular Vesicles and Cellular Homeostasis. Annual review of biochemistry. 2025. doi:10.1146/annurev-biochem-100924-012717
Yuki K, Koutsogiannaki S. Obesity as a Risk Factor in Pediatric Sepsis: A Retrospective Comparative Study Under the Phoenix Definition. Journal of clinical medicine. 2025;14(5). doi:10.3390/jcm14051568
Fittolani G, Callahan AJ, Loas A, Pentelute BL. Automated fast-flow synthesis of the immune checkpoint receptors PD-1 and PD-L1. Chemical communications (Cambridge, England). 2025. doi:10.1039/d4cc05982d
Chakraborty C, Talluri S, Binder M, et al. Loss of BCL7A Permits IRF4 Transcriptional Activity and Cellular Growth in Multiple Myeloma. Blood. 2025. doi:10.1182/blood.2024026588